ArticleActa parasitologica2026
The Effect of Elaeagnus angustifolia L. Leaf Extract on Encephalitozoon intestinalis, Acanthamoeba castellanii, and Leishmania major.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeParasitic diseases are a major global health concern. Treating these diseases presents many challenges. Elaeagnus angustifolia L. (EA) is renowned for its anti-oxidant, anti-inflammatory, and anti-microbial properties, and various parts of the plant are used to treat a variety of ailments. This study aims to evaluate the in vitro activity of the EA leaves against Encephalitozoon intestinalis (E. intestinalis), Acanthamoeba castellanii (A. castellanii), and Leishmania major (L. major) at different concentrations and incubation times.
methodsSpore load was measured by real-time PCR using an infection model in human kidney epithelial (HEK) 293 cells for E. intestinalis. The viability of A. castellanii trophozoites and cysts, and L. major promastigotes was determined by trypan blue staining and hemocytometry.
resultsElaeagnus angustifolia L. leaf extract significantly reduced the spore DNA load in E. intestinalis infections at a concentration of 5 µg/mL, but was ineffective at lower concentrations. The extract decreased the viability of A. castellanii trophozoites and cysts, as well as L. major promastigotes, at varying rates depending on the time and dose. It was particularly effective against A. castellanii cysts at low doses.
conclusionThe biological activity of the plant extract obtained from the leaves of Elaeagnus angustifolia L. against three different parasites suggests that it could be used as a promising alternative in the treatment of parasitic infections.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.